Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian Cancer

基质 队列 卵巢癌 肿瘤科 组织微阵列 癌症 内科学 浆液性癌 生物标志物 医学 比例危险模型 无进展生存期 队列研究 化疗 病理 生物 免疫组织化学 生物化学
作者
Emil Lou,Valentino Clemente,Marcel Grube,Axel Svedbom,Andrew C. Nelson,Freya Blome,Annette Staebler,Stefan Kommoss,Martina Bazzaro
出处
期刊:JAMA network open [American Medical Association]
卷期号:7 (2): e240407-e240407 被引量:5
标识
DOI:10.1001/jamanetworkopen.2024.0407
摘要

IMPORTANCE Platinum-based chemotherapy is the backbone of standard-of-care treatment for patients with advanced-stage, high-grade serous carcinoma (HGSC), the most common form of ovarian cancer; however, one-third of patients have or acquire chemoresistance toward platinum-based therapies. OBJECTIVE To demonstrate the utility of tumor-stroma proportion (TSP) as a predictive biomarker of chemoresistance of HGSC, progression-free survival (PFS), and overall survival (OS). DESIGN, SETTING, AND PARTICIPANTS This prognostic study leveraged tumors from patients with HGSC in The Cancer Genome Atlas (TCGA) cohort (1993-2013) and an independent cohort of resected clinical specimens from patients with HGSC (2004-2014) available in diagnostic and tissue microarray formats from the University of Tübingen in Germany. Data analysis was conducted from January 2021 to January 2024. EXPOSURE Diagnosis of HGSC. MAIN OUTCOMES AND MEASURES Principal outcome measures were the ability of TSP to predict platinum chemoresistance, PFS, and OS. Using hematoxylin and eosin–stained slides from the Tübingen cohort (used for routine diagnostic assessment from surgical specimens) as well as tissue microarrays, representative sections of tumors for scoring of TSP were identified using previously evaluated cutoffs of 50% stroma or greater (high TSP) and less than 50% stroma (low TSP). Digitized slides from the TCGA Cohort were analyzed and scored in a similar fashion. Kaplan-Meier time-to-event functions were fit to estimate PFS and OS. RESULTS The study included 103 patients (mean [SD] age, 61.6 [11.1] years) from the TCGA cohort and 192 patients (mean [SD] age at diagnosis, 63.7 [11.1] years) from the Tübingen cohort. In the TCGA cohort, there was no significant association of TSP levels with chemoresistance, PFS, or OS. However, in the Tübingen cohort, high TSP was associated with significantly shorter PFS (HR, 1.586; 95% CI, 1.093-2.302; P = .02) and OS (hazard ratio [HR], 1.867; 1.249-2.789; P = .002). Patients with chemoresistant tumors were twice as likely to have high TSP as compared to patients with chemosensitive tumors (HR, 2.861; 95% CI, 1.256-6.515; P = .01). In tissue microarrays from 185 patients from the Tübingen cohort, high TSP was again associated with significantly shorter PFS (HR, 1.675; 95% CI, 1.012-2.772 P = .04) and OS (HR, 2.491; 95% CI, 1.585-3.912; P < .001). CONCLUSIONS AND RELEVANCE In this prognostic study, TSP was a consistent and reproducible marker of clinical outcome measures of HGSC, including PFS, OS, and platinum chemoresistance. Accurate and cost-effective predictive biomarkers of platinum chemotherapy resistance are needed to identify patients most likely to benefit from standard treatments, and TSP can easily be implemented and integrated into prospective clinical trial design and adapted to identify patients who are least likely to benefit long-term from conventional platinum-based cytotoxic chemotherapy treatment at the time of initial diagnosis.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
风趣的寻凝完成签到 ,获得积分10
刚刚
多情的寻真完成签到,获得积分10
刚刚
DOC_XIONG的应助被ale采纳,获得10
刚刚
刻苦以云完成签到 ,获得积分10
1秒前
1秒前
阿飞大师完成签到,获得积分10
1秒前
XPDrake完成签到,获得积分10
1秒前
JL完成签到 ,获得积分10
1秒前
TheDing完成签到,获得积分10
2秒前
武陵济世完成签到,获得积分10
2秒前
horse888完成签到,获得积分10
3秒前
风不言喻完成签到,获得积分10
3秒前
Ya_Yen完成签到,获得积分10
3秒前
zjh完成签到 ,获得积分10
4秒前
5秒前
27完成签到 ,获得积分10
6秒前
6秒前
秋月明完成签到,获得积分10
6秒前
科研通AI6.2的应助被武陵济世采纳,获得10
6秒前
墨z完成签到 ,获得积分10
7秒前
小亮哈哈完成签到,获得积分0
7秒前
奥特曼发布了新的文献求助30
7秒前
小水蜜桃完成签到 ,获得积分10
8秒前
8秒前
xiaoxu小徐完成签到 ,获得积分10
8秒前
娃哈哈完成签到,获得积分10
9秒前
顾志成发布了新的文献求助10
10秒前
周海涛发布了新的文献求助10
10秒前
自由念露完成签到 ,获得积分0
11秒前
独特的飞烟完成签到,获得积分10
13秒前
14秒前
14秒前
kkk完成签到,获得积分10
15秒前
bkagyin的应助被奥特曼采纳,获得10
15秒前
sls完成签到,获得积分10
15秒前
文静的行恶完成签到,获得积分10
16秒前
odell完成签到,获得积分10
17秒前
顺心的皮卡丘完成签到 ,获得积分10
19秒前
鹤雪完成签到,获得积分10
19秒前
fashing完成签到,获得积分10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159151
求助须知:如何正确求助?哪些是违规求助? 9554617
关于积分的说明 21719982
捐赠科研通 7748814
什么是DOI,文献DOI怎么找? 3427149
关于科研通互助平台的介绍 2552091
邀请新用户注册赠送积分活动 2471436